Related Experiment Video
Updated: Jul 17, 2026

Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess
Published on: June 1, 2022
The Role of the Mitochondrial Permeability Transition Pore in Chronic Pain
Yuye Chen1, Xiaotong Chen1, Hu Zang1
1Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Abstract:
The mitochondrial Permeability Transition Pore (mPTP) has been implicated in cell death, energy failure, and oxidative stress. Emerging evidence suggests that mPTP may also contribute to the development and maintenance of chronic pain, although evidence remains limited and the underlying mechanisms are not fully understood. This narrative review summarizes current findings from experimental and clinical chronic pain models and discusses how mPTP-mediated mitochondrial dysfunction may promote central sensitization and pain persistence through reactive oxygen species accumulation, neuroinflammation, apoptosis, and metabolic failure. Pharmacological strategies targeting mPTP and their therapeutic implications are further discussed. Finally, future perspectives are proposed, including mechanistic investigations, drug discovery, and clinical translation. This review highlights mPTP as a promising therapeutic target and provides a focused framework for future studies exploring mitochondrial mechanisms in chronic pain.
Insights
The mitochondrial permeability transition pore (mPTP) may drive chronic pain by causing mitochondrial dysfunction. Targeting mPTP offers a potential new strategy for treating persistent pain conditions.
Area of Science:
- Mitochondrial biology
- Neuroscience
- Pain research
Background:
- The mitochondrial permeability transition pore (mPTP) is linked to cell death and oxidative stress.
- Limited evidence suggests mPTP involvement in chronic pain development and maintenance.
- Underlying mechanisms of mPTP in chronic pain are not fully understood.
Purpose of the Study:
- To review current findings on mPTP in chronic pain models.
- To discuss mPTP-mediated mitochondrial dysfunction in pain persistence.
- To explore pharmacological strategies targeting mPTP for pain management.
Main Methods:
- Narrative review of experimental and clinical chronic pain studies.
- Analysis of mPTP's role in central sensitization and pain persistence.
- Discussion of reactive oxygen species, neuroinflammation, apoptosis, and metabolic failure.
Main Results:
- mPTP-mediated mitochondrial dysfunction may promote chronic pain.
- Mechanisms include reactive oxygen species, neuroinflammation, apoptosis, and metabolic failure.
- mPTP inhibitors show therapeutic potential for chronic pain.
Conclusions:
- mPTP is a promising therapeutic target for chronic pain.
- Further research is needed for mechanistic investigations and clinical translation.
- This review provides a framework for studying mitochondrial mechanisms in pain.
Related Concept Videos
Analgesia and Pain Management
Nociception
Pain
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...